Glycos Biotechnologies, Inc., an emerging biochemical company applying metabolic engineering and microbiology innovations for the production of sustainable biochemicals, exchanged definitive agreements with Malaysian Bio-XCell for the establishment of an industrial biochemical plant and biotechnology R&D facility in Malaysia.
GlycosBio announced in May its partnership with Malaysian Bio-XCell Sdn. Bhd. to build an industrial biochemical plant and a biotechnology research and development facility to be operational in 2012. (Earlier post.) The company plans to focus much of its initial research and development efforts on creating isoprene to support Malaysia’s rubber industry.
For Malaysia, isoprene is a strategic product because of the large domestic latex industry and where we plan to focus much of our R&D efforts. With construction underway, our long-term strategy includes further expansion in Malaysian and across Southeast Asia forming joint venture partnerships with existing petrochemical, oleochemical, and biofuel producers and to partner with end market players in the development of advanced biochemicals.—Richard Cilento, Chief Executive Officer of Glycos Biotechnologies
Paul Campbell, Chief Science Officer for GlycosBio, will participate in a panel at the BioMalaysia 2010 Conference. The panelists will provide an overview of green chemicals and biomaterials that can be created from renewable resources in addition to the fermentative utilization of glycerol and fatty acids for the production of bulk chemicals.
GlycosBio has engineered a series of metabolic pathways that can produce nearly a dozen chemical intermediaries including ethanol, succinic acid, propanediols, and lactic acid from a variety of non food-based feedstocks including glycerol, cellulosic sugar, plant oils, algae and fatty acids. Given the reach and flexibility of our platform, we can easily adapt and work with a market’s specific need to create a variety of high value chemicals. For this reason, we continue to be very excited about our work in Malaysia and are honored to be part of such a distinguished group of industry experts at BioMalaysia 2010.—Paul Campbell